Aden Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.21 Cr
- Satisfied Charges ₹ 10.18 Cr
- Revenue Growth -13.91%
- Profit Growth 114.08%
- Ebitda -9.18%
- Net Worth 1.62%
- Total Assets -3.24%
About Aden Pharmaceuticals
Aden Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 August 2006 and has a history of 18 years and five months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.21 Cr. The company has closed loans amounting to ₹10.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dilipkumar Dholaria, Hasmukhbhai Antala, and Ashokbhai Savalia serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232GJ2006PTC048957
-
Company No.
048957
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Aden Pharmaceuticals Private Limited offer?
Aden Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Anti Infective API.
Who are the key members and board of directors at Aden Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilipkumar Dholaria
|
Director | 28-Aug-2006 | Current |
|
Hasmukhbhai Antala
|
Director | 03-Jan-2008 | Current |
|
Ashokbhai Savalia
|
Director | 28-Aug-2006 | Current |
Financial Performance of Aden Pharmaceuticals.
Aden Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.91% decrease. The company also saw a substantial improvement in profitability, with a 114.08% increase in profit. The company's net worth moved up by a moderate rise of 1.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aden Pharmaceuticals?
In 2023, Aden Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Venture Pharmaceuticals Private LimitedHasmukhbhai Antala is a mutual person
Charges (Loans)
₹32.10 M
₹101.81 M
Charges Breakdown by Lending Institutions
- Bank Of India : 3.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2024 | Bank Of India | ₹3.21 Cr | Open |
| 12 May 2017 | Others | ₹3.43 Cr | Satisfied |
| 11 Apr 2017 | Others | ₹2.30 Cr | Satisfied |
| 02 Apr 2013 | Bank Of India | ₹1.00 Cr | Satisfied |
| 06 Dec 2008 | Bank Of India | ₹2.15 Cr | Satisfied |
How Many Employees Work at Aden Pharmaceuticals?
Aden Pharmaceuticals has a workforce of 31 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aden Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aden Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
